Abstract 891
Case Summary
A 19-year-old man, known case of HIV infection, came to hospital with progressive headache for 2 months. Physical examination revealed impaired upward gaze and papilledema both eyes. MRI Brain revealed suprasellar and pineal region mass causing obstructive hydrocephalus. MRI whole spine showed leptomeningeal metastasis. Serum HCG was 3.1 mIU/ml, AFP was 1.12 ng/ml and LDH was 365 U/L. He was implanted ventriculoperitoneal shunt to decrease intracranial pressure. CSF HCG was 20.42 mIU/ml. After the operation, his clinical improved. MDT decided to perform craniospinal radiation. After 1 fraction of radiotherapy, his consciousness was deteriorated. CT brain showed seeding lesions in bilateral frontal horns of the lateral ventricle and pericollosal of bilateral frontal lobes and the fourth ventricle. Radiotherapy was withheld and chemotherapy (EP regimen) was commenced on March 2017. His clinical was obviously improved within a week after chemotherapy. After 3 cycles, MRI of the brain showed complete resolution of the intracranial masses. The 4th cycle of EP regimen was continued and followed by craniospinal radiation which has completed in July 2017. In February 2018, the serum LDH was rising to 880 U/L. He was asymptomatic. MRI of the brain and whole spine wasn’t show residual or recurrence tumor. In May 2018, serum LDH was repeated and increased to 2574 U/L. The serum HCG increased to 12.09 mIU/ml. CT chest and whole abdomen revealed several peritoneal nodules, measured about 1.0-12.7cm. Salvage chemotherapy, TIP regimen, has been commenced from June 2018. The tumor markers were repeated before starting the second cycle. Serum LDH and serum HCG were 238 U/L and less than 0.1 mIU/ml, respectively. Standard treatment of pineal germinoma is craniospinal radiation with or without chemotherapy. This case has shown that in one who is not suitable for radiation, induction treatment with systemic chemotherapy may be considered. Furthermore chemotherapy, EP regimen, also shows excellent blood-brain barrier penetration leading to a good CNS response. Although extracranial metastasis of primary pineal germinoma is rare but is able to be found in one who performs VP shunt via CSF drop metastasis mechanism.
Editorial acknowledgement
Clinical trial identification
Resources from the same session
780 - The adipocyte suppresses the inhibitory role of hsa_circ_0000190 in the metastasis of breast cancer cells
Presenter: Xiu Chen
Session: Poster display - Cocktail
Resources:
Abstract
782 - CircASS1 suppressed the invasion and metastasis ability of breast cancer cell line by targeting gene ASS1 and harboring miR-4443
Presenter: Junchen Hou
Session: Poster display - Cocktail
Resources:
Abstract
916 - Ex-vivo drug sensitivity of primary breast cancer stems cell populations to potentiate therapeutic strategy for treatment resistant breast cancer
Presenter: Sourav Nandi
Session: Poster display - Cocktail
Resources:
Abstract
928 - Molecular Tumor Board (MTB): development of clinical pathways for precision medicine. Experiences of Center for Breast cancer at National cancer center, Korea
Presenter: In Hae Park
Session: Poster display - Cocktail
Resources:
Abstract
1274 - MicroRNA based immune response signature identifies poor prognostic subgroup within ER negative breast cancers
Presenter: Savitha Rajarajan
Session: Poster display - Cocktail
Resources:
Abstract
165 - The clinical efficacy of apatinib combined with Xeloda in advanced triple negative breast cancer
Presenter: YiHui Li
Session: Poster display - Cocktail
Resources:
Abstract
561 - Quality of life and psychosocial needs of metastatic breast cancer patients
Presenter: Tahir Mehmood
Session: Poster display - Cocktail
Resources:
Abstract
697 - TC-1 mediate the TBC1D3 oncogene induced migration of MCF-7 breast cancer cells
Presenter: Yong Shen
Session: Poster display - Cocktail
Resources:
Abstract
784 - RelB facilitates cell migration and invasion in breast cancer via MMP1 upregulation
Presenter: Mei Wang
Session: Poster display - Cocktail
Resources:
Abstract
921 - Re-challenging eribulin in patients with ER+HER2- metastatic breast cancer: A single-institution experience
Presenter: Junichiro Watanabe
Session: Poster display - Cocktail
Resources:
Abstract